GelSana Therapeutics, Inc.

New Filing
CIK: 0002002665·Biotechnology·DELAWARE·Filed: Dec 4, 2023
Total Offering

$3,181,752

Amount Sold

$2,476,750

Investors

14

First Sale

Nov 20, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Melissa Krebs
Related Person
Mike Freeman
Related Person
Jim Kasic
Related Person

Company

GelSana Therapeutics, Inc.

12635 E MONTVIEW BLVD STE 216

AURORA, CO, 80045

(216) 502-0901

SEC Filing

0002002665-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
GelSana Therapeutics, Inc. Form D Filing — $3,181,752 | FilingFlow